Cisatracurium Besylate Injection
Product Images NDC 0781-3153

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0781-3153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cis Nonpres Image 01

Chemical structure of cisatracurium besylate, showing its molecular components including aromatic rings, methoxy groups, quaternary ammonium ions, and bisbenzenesulfonate salt moiety.*

FDA Label Image

Cis Nonpres Image 02

A scatter plot displaying data points representing percentage changes, with heart rate (HR) on the vertical axis ranging from -60% to +60% and mean arterial pressure (MAP) on the horizontal axis ranging from -60% to +60%. Data points are mostly clustered near the center.*

FDA Label Image

Cis Nonpres Image 03

A scatter plot graph depicting two variables labeled as MAP (Mean Arterial Pressure) on the horizontal axis and T HR (likely Heart Rate) on the vertical axis, both ranging from -60% to +60%. The plot shows a cluster of data points centered around the origin with a dispersed pattern.*

FDA Label Image

Cis Nonpres Image 04

Packaging label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) by Sandoz Inc. This is a 5 mL single-dose vial for intravenous injection. The label includes warnings such as "Paralyzing Agent" and storage instructions to refrigerate. Manufactured in India for Sandoz Inc., Princeton, NJ. The label dimensions are indicated as 35 mm wide panels.*

FDA Label Image

Cis Nonpres Image 05

Packaging label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL), a sterile, nonpyrogenic single-dose vial for intravenous injection. Label includes warnings about paralyzing agent effects, storage instructions, and that it is for ICU use only. Manufactured by Sandoz Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.